Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions Before the Delivery
NCT ID: NCT03883867
Last Updated: 2020-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2019-03-08
2020-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions
NCT02294383
Cross-sectional Area of Pubovisceral Muscle in Nulliparous and Primiparous Women
NCT05800678
Trans-perineal Ultrasound & Dynamic Pelvic Magnetic Resonance Imaging in Assessment of Pelvic Floor Dysfunction.
NCT03241836
Pelvic Floor Muscle Assessment at 3-and 4-dimensional Transperineal Ultrasound
NCT03950479
The Effect of Pregnancy and Labour on the Pelvic Floor Diagnosed With 3D and 4D Ultrasound
NCT01045135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The benefits to physicians, patients and society are expected to be significant because the painful event in woman's life , given the large proportion of women suffer PFD caused by childbirth.
This new system may open a new technical capability in woman's healthcare and change the established clinical practice.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
The subject population will involve 10 non-pregnant women. The tactile imaging reprifucibility sub-group will include 5 non-pregnant subjects with 2 tactile imaging examinations completed in one session. All other subjects will have a single tactile imaging examination.
No interventions assigned to this group
Pregnant
The subject population will involve 10 pregnant women without known complications at 36-37 weeks of pregnancy scheduled for a regular examination. All pregnant subjects should be examined weekly after completing 36th week of an uncomplicated pregnancy. Routine gynecologic examination includes external and internal obstetrical examination.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant women after completed 35th week of pregnancy with fetus in vertex position and premise of vaginal delivery (Division of Maternal-Fetal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ)
Exclusion Criteria
* HIV or hepatitis B positive serology
* Warty lesions on the vulva
* Extensive varicose veins on the vulva
* Aactive skin infection or ulceration within the vagina/vulva
* Presence of vaginal septum
* Severe hemorrhoids
* Stillbirth or extensive congenital abnormalities of the fetus
21 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advanced Tactile Imaging, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Egorov, PhD
Role: PRINCIPAL_INVESTIGATOR
Advanced Tactile Imaging, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers The State University Of New Jersey
New Brunswick, New Jersey, United States
Princeton Urogynecology
Princeton, New Jersey, United States
Department of Gynecology and Obstetrics University Hospital
Pilsen, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VTI 10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.